Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @nextlevel_LS
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @nextlevel_LS
-
NextLevel LS proslijedio/la je Tweet
We had a great start of the year!
In the remaining 11 months of #2020, we'll continue the journey of bringing the right treatment to the right patient at speed.
Thanks so much to @EU_Commission,@MECCambridge,@nextlevel_LS and@nzz_konferenzen.https://glimpse.link/l/OjUpR4mHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join 30+ speakers including
@JNJCares,@SmithNephewPLC &@EdwardsLifesci in Zurich: http://bit.ly/33GMzL4 to learn how medical device market leaders are achieving better#sales force & distributor performance, as well as#digital#marketing effectiveness.pic.twitter.com/8iyeO4KSO6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join speakers from
@pfizer ,@abbvie ,@AstellasEurope,@Novartis & other 30+ speakers in London: http://bit.ly/2KgaKrX & learn how to drive your#medicalAffairs team & enhance KOL & stakeholder engagement at all levels.pic.twitter.com/drXd0dW0Fa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Why should
#medicalaffairs professionals & MSLs learn#persuasion skills? Read full article here: https://bit.ly/2U1taCF pic.twitter.com/yzMxCGtlzY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NextLevel LS proslijedio/la je Tweet
Enjoyed chairing session on
#AI@nextlevel_LS. Impressive successes by Pieter Peeters@JanssenGlobal,@sam_o_cooper@PhenomicAI, Eike Staub@merckgroup and more. So exciting to see applications throughout drug development.@agenus_bioHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Joerg Berghausen,
@Novartis, on predictive analytics &#machinelearning in drug development optimization @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/OpwcXZ57rr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sam Cooper,
@PhenomicAI, on#machinelearning & high content imaging for drug discovery @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/t5b5E4JRTQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
David Ruau,
@Bayer, on why & how to detect a tumor-driving#molecular event in routine diagnosis data-#histogenomics case study @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/KsadCm9Hcd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Brian Burke,
@HorizonGenomics, on#gene editing based#genomics for drug discovery @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/r79URUC1fp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Michael Lange,
@Roche , on building an#AI tool to query external data for drug#discovery @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/jkfNYLXQIY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jeremy Everett,
@UniofGreenwich, on#metabolic phenotyping for#precision medicine @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/XUSEda3Gdq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Winston Hide,
@harvardmed &@BIDMChealth on precision medicine tools for drug development @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/CeofYB4WyQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Eike Staub,
@Merck, on building an#omics platform for#biomarker R&D @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/64k5JT2sMn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
John Castle,
@Agenus_Bio, on using#AI to tackle immuno-oncology @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/lHyBoDxByF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pieter Peeters,
@JanssenGlobal, on collaborative#machinelearning approach to drug#discovery & design @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/khUMbnTniL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Panel Discussion: Technology & the future of medicine with experts from
@Bayer,@Roche,@SiemensHealth,@googlecloud &@OKRATechAI @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/46V1B1T3LY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Benoit Marchal,
@Roche, on#Medical#Data: What about empowering the patients while keeping their identity well protected? @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/RhucAoJBPs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alexander Scheer,
@ERYTECH_PHARMA, on new therapeutic options in#oncology:#Innovation by using human red blood cells to treat#cancer @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/cBrsz3rSgD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alexander Krupp from
@Bayer sharing how#patient benefit comes from a clear#digital R&D integration strategy @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/PfSvY1hK32
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nazar Rasul from
@SiemensHealth showing us the future of healthcare with#virtual livers, digital twins & data-based#outcome prediction! @ our R&D#Data Intel Forum 2020 in Basel: https://bit.ly/2tShEid pic.twitter.com/yaPRh94lf1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.